2017 AHA/ACC STEMI and NSTEMI Myocardial Infarction Clinical Performance and Quality Measures No. Measure Title Care Setting Attribution Measure Domain Performance Measures PM-1 Aspirin at Arrival Inpatient Facility or Provider Level Effective Clinical Care PM-2 Aspirin Prescribed at Discharge Inpatient Facility or Provider Level Effective Clinical Care PM-3 Beta Blocker Prescribed at Discharge Inpatient Facility or Provider Level Effective Clinical Care PM-4 High-Intensity Statin Prescribed at Discharge Inpatient Facility or Provider Level Effective Clinical Care PM-5 Evaluation of LVEF Inpatient Facility or Provider Level Effective Clinical Care PM-6 ACEI or ARB Prescribed for LVSD Inpatient Facility or Provider Level Effective Clinical Care PM-7 Time to Fibrinolytic Therapy* Inpatient Facility or Provider Level Communication and Care Coordination PM-8 Time to Primary PCI* Inpatient Facility or Provider Level Communication and Care Coordination PM-9 Reperfusion Therapy* Inpatient Facility or Provider Level Effective Clinical Care PM-10 Time From ED Arrival at STEMI Referral Facility to ED Discharge From STEMI Referral Facility in Patients Transferred for Primary PCI* Inpatient Facility Level Communication and Care Coordination PM-11 Time From FMC (At or Before ED Arrival at STEMI Referral Facility) to Primary PCI at STEMI Receiving Facility Among Transferred Patients* Inpatient Facility Level Communication and Care Coordination PM-12 Cardiac Rehabilitation Patient Referral From an Inpatient Setting Inpatient Facility or Provider Level Communication and Care Coordination PM-13 PY12 Receptor Inhibitor Prescribed at Discharge Inpatient Facility or Provider Level Effective Clinical Care PM-14 Immediate Angiography for Resuscitated Out-of-Hospital Cardiac Arrest in STEMI Patients* Inpatient Facility or Provider Level Effective Clinical Care PM-15 Noninvasive Stress Testing Before Discharge in Conservatively Treated Patients Inpatient Facility or Provider Level Efficiency and Cost Reduction PM-16 Early Cardiac Troponin Measurement (Within 6 Hours of Arrival) Inpatient Facility or Provider Level Efficiency and Cost Reduction PM-17 Participation in 1 Regional or National Registries That Include Patients With Acute Myocardial Infarction Registry Inpatient Facility Level Community, Population, and Public Health Quality Measures QM-1 Risk Stratification of NSTEMI Patients With a Risk Score Inpatient Facility or Provider Level Effective Clinical Care QM-2 Early Invasive Strategy (Within 24 Hours) in High-Risk NSTEMI Patients Inpatient Facility or Provider Level Effective Clinical Care QM-3 Therapeutic Hypothermia for Comatose STEMI Patients With Out- of-Hospital Cardiac Arrest* Inpatient Facility or Provider Level Effective Clinical Care QM-4 Aldosterone Antagonist Prescribed at Discharge Inpatient Facility or Provider Level Effective Clinical Care QM-5 Inappropriate In-Hospital Use of NSAIDs Inpatient Facility or Provider Level Patient Safety QM-6 Inappropriate Prescription of Prasugrel at Discharge in Patients With a History of Prior Stroke or TIA Inpatient Facility or Provider Level Patient Safety QM-7 Inappropriate Prescription of High-Dose Aspirin With Ticagrelor at Discharge Inpatient Facility or Provider Level Patient Safety *These measures apply only to patients with STEMI. 